MARLBOROUGH, Mass.-- (BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced the granting of a CE Mark to the LOCalizer™ wireless radio frequency identification (RFID) breast lesion localization ...
By localization method, wire localization held the largest market share in 2023 due to its long-standing clinical use, affordability, and widespread availability. Despite increasing adoption of ...
Breast lesion localization plays a crucial role in guiding precise surgical interventions and improving patient outcomes in breast cancer treatment. With the rising prevalence of breast cancer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results